Articles On Apiam Animal Health (ASX:AHX)

ASX healthcare sector fell 4.83% in October and is down more than 19% YTD CSL shares fall more than 15% on October 28 after management trims FY26 guidance Nyrada surges 165% in October on board changes and progress in phase 2a trial    Wi...

Apiam Animal Health agrees to $160m takeover by Adamantem Capital Lumos Diagnostics and Vitasora expand US healthcare reach with new trials and rollouts Regis Healthcare adds two Victorian aged care homes in $45m deal   The ASX healthcare...

Highlights Mixed performance across Australian equities as markets consolidate Strength in construction and industrial players offsets gold and retail softness Global trade tensions weigh on outlook for domestic manufacturer...

Highlights James Hardie surges amid stronger guidance update NRW Holdings gains traction on upgraded outlook Gold and AI sectors capture investor attention A comprehensive look at the ASX 200 live today, featuring market movers li...

The S&P ASX 200 Health Care index fell 13.21% in August as a tough reporting season weighed on sector CSL had its biggest ever one day fall on August 19, down 17% following softer FY25 results and restructure plans Despite the broader...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin An additional news report on the recommendation, valuation, forecast and opinion cha...

  Highlights ASX 200 reaches new record with broad sector gains led by telecoms and information technology. Kaili Resources (ASX:KLR) and Mount Burgess Mining (ASX:MTB) record strong activity in the resources sector. REA Gr...

Shares in rural veterinary group Apiam Animal Health (ASX: AHX) closed almost 45 per cent higher today after private equity group Adamantem Capital Management lobbed a $161.8 million takeover bid for the Bendigo-based company. The shares c...

Highlights ASX achieves new record high for 2025 Telecoms and critical minerals outperform Strategic acquisitions shape gold and animal health sectors The ASX continued its upward trajectory, marking the 17th record hi...

ASX sets 17th intraday high for the year at 8963 Closes out trade at record 8959.3 points Broad sector gains continue with eight of 11 higher   Bulls set the tone for fresh week of trade It wasn’t looking this way as we chowed down for lu...

Apiam Health shares surge 50% on $124 million private equity takeover approach Audeara’s update is news to investor ears Dorsavi’s robotic moves result in $5 million raising   Apiam Animal Health (ASX:AHX) has received a $124 million non...

The S&P ASX 200 Health Care index rose 9.05% in July with rotation into the sector gaining momentum  Lumos soared 170% in July after six-year exclusive deal valued at up to US$317 million with PHASE Scientific for distribution of Febri...

New blood test reveals hidden muscle damage in racehorses Proteomics’ OxiDx helps trainers spot injuries early and avoid breakdowns ASX-listed stocks with exposure to the animal sector.   In the high-octane world of thoroughbred racing, m...

The ASX 200 Health Care Index fell 1.05% in June and remains the worst performing sector YTD down 6.64% Morgans healthcare analyst Iain Wilkie said June likely saw some tax loss selling before EOFY  Amplia up 300% in June after complete re...

The S&P/ASX 200 Health Care Index rose 1.59% in May but remains worst performing sector YTD down 5.65% Morgans healthcare analyst Iain Wilkie said US President Donald Trump’s trade and health policies continue to impact sector Lumos up...

The S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Morgans healthcare analyst Iain Wilkie said April was a marked improvement on recent months Several approvals during April, including for EBR...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin An additional news report on the recommendation, valuation, forecast and opinion cha...

The S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Morgans healthcare analyst Iain Wilkie said several factors caused investor jitters in February including job cuts to US FDA  Pacific Edge was...

The S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024  Mesoblast surged 52% in December after the US FDA approved its cell therapy Ryoncil for treatment of paediatric GvHD Percheron plunged 91% in Dece...

Householders are cutting back expenditure – but not on their pets Mad Paws is an Airtasker-style marketplace to connect owners with minders Apiam Animal Health is the only other listed exposure to the $33 billion petcare market   Accordin...

Householders are cutting back expenditure – but not on their pets Mad Paws is an Airtasker-style marketplace to connect owners with minders Apiam Animal Health is the only other listed exposure to the $33 billion petcare market   Accordin...

The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX  Paradigm Biopharmaceuticals rose 151% in Novembe...

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

Bendigo-based vet services business Apiam Animal Health (ASX: AHX) has been flagged as a potential takeover target in a sector that has rarely been out of the spotlight over the past five years following a series of big-ticket buyouts. Api...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Equities overnight had another positive session, both in the US and in Europe, and t...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

  On Friday, the Dow Jones Industrial Average hit a new record high as traders processed fresh data indicating ongoing progress in curbing inflation. Wall Street also celebrated its third consecutive week of gains. The 30-stock Dow increase...

On Friday, the Dow Jones Industrial Average hit a new record high as traders processed fresh data indicating ongoing progress in curbing inflation. Wall Street also celebrated its third consecutive week of gains. The 30-stock Dow increased...

Birth rates decline as people choose careers and pets Global pet industry is benefitting from this, to grow significantly by 2030 Ethical investing could thrive in sustainable pet product demand   The conversation around motherhood is evo...

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

  US stocks closed slightly higher on Tuesday as investors looked ahead to a crucial earnings report from Nvidia. The broad-based S&P 500 gained 0.16 per cent to finish at 5,625.80, while the tech-heavy Nasdaq Composite rose 0.16 per ce...

S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July   The S&P/ASX 200 Health Care index [XHJ]...

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...

Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month    The phrase ‘you are what you eat’ was coined almost a c...

ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month   The S&P/ASX 200 Health Care [XHJ] had a soft month in April...

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors   The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr...

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

  Local markets end Friday (and the week) ahead circa 0.4pc IT sector booms 1.5pc Small caps led by WhiteHawk   The ASX200 has kept its head and ended Friday higher thanks to a boost from local tech stocks. At 4.15pm on Friday February 23...

Apiam surged as high as +27pc this morning Cleanspace had a strong first half AVITA Medical’s Q4 revenue also climbed higher   Apiam Health jumps much higher after strong H1 Rural veterinary business, Apiam Animal Health (ASX:AHX), jumped...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help...

The ASX benchmark has ended Tuesday higher 8 of 11 sectors in the green Small caps led by Plenti Group (ASX:PLT), InteliCare (ASX:ICR) The local market has trimmed some of its early gains (wussed out) after jumping out of the blocks in...

Benchmark ASX index finishes ever so slightly up ASX Sectors led by Financial, IT, Property and Materials Small cap gainers: RBL, PIL, and LPI   Here’s how we ended on Thursday. Local markets largely did okay, and then wilted when we go...

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, who made announcements today.   ICYMI Leader...

Let's talk about the unbreakable bond between households and their pets, and about the companies that offer exposure -Demand for premium goods and services for pets is strong and resilient-Australia has one of the highest pet ownership rate...

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

Humanisation of pets trend continues to benefit ASX pet stocks Apiam Animal Health reports ~25% increase in revenue as pet owners seek higher standards of care Mad Paws on track for operating EBITDA break even target by mid-2023 as profit...

Rural veterinary clinic aggregator Apiam Animal Health (ASX: AHX) has corralled five new clinics in high-growth regional areas of NSW through two separate acquisitions worth $11.2 million. The buyouts more than double the mixed animal clin...